{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T00:17:09Z","timestamp":1648685829122},"reference-count":20,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","transplantation-proceedings.org","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transplantation Proceedings"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/j.transproceed.2017.05.006","type":"journal-article","created":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T19:15:57Z","timestamp":1503688557000},"page":"1634-1638","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Acute Graft Rejection and Formation of De Novo Donor-Specific Antibodies Triggered by Low Cyclosporine Levels and Interferon Therapy for Recurrent Hepatitis C Infection After Liver Transplantation: A Case Report"],"prefix":"10.1016","volume":"49","author":[{"given":"R.","family":"Nakano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Ohira","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Ishiyama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Ide","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"T.","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Tahara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Arihiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Chayama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Y.","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Ohdan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.transproceed.2017.05.006_bib1","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1111\/ajt.12212","article-title":"De novo donor-specific HLA antibodies decrease patient and graft survival in liver transplant recipients","volume":"13","author":"Kaneku","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2017.05.006_bib2","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1111\/ajt.12651","article-title":"Prevalence, incidence and risk factors for donor-specific anti-HLA antibodies in maintenance liver transplant patients","volume":"14","author":"Del Bello","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2017.05.006_bib3","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jhep.2010.11.012","article-title":"Immune-mediated complications of the graft in interferon-treated hepatitis C positive liver transplant recipients","volume":"55","author":"Selzner","year":"2011","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.transproceed.2017.05.006_bib4","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.humimm.2010.02.021","article-title":"Development of antibodies to human leukocyte antigen precedes development of antibodies to major histocompatibility class I-related chain A and are significantly associated with development of chronic rejection after human lung transplantation","volume":"71","author":"Angaswamy","year":"2010","journal-title":"Hum Immunol"},{"key":"10.1016\/j.transproceed.2017.05.006_bib5","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1111\/j.1600-6143.2006.01711.x","article-title":"Extremely high association between appearance of HLA antibodies and failure of kidney grafts in a five-year longitudinal study","volume":"7","author":"Mao","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2017.05.006_bib6","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/S0041-1345(00)02431-3","article-title":"IVIG rescue therapy in renal transplantation","volume":"33","author":"Luke","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/j.transproceed.2017.05.006_bib7","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1097\/00007890-199812150-00008","article-title":"Plasma exchange and tacrolimus-mycophenolate rescue for acute humoral rejection in kidney transplantation","volume":"66","author":"Pascual","year":"1998","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2017.05.006_bib8","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1111\/j.1600-6143.2004.00454.x","article-title":"Rituximab as treatment for refractory kidney transplant rejection","volume":"4","author":"Becker","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2017.05.006_bib9","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1016\/j.suc.2013.08.002","article-title":"Management of antibody-mediated rejection in transplantation","volume":"93","author":"Sadaka","year":"2013","journal-title":"Surg Clin North Am"},{"key":"10.1016\/j.transproceed.2017.05.006_bib10","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/TP.0b013e3181c6ff8d","article-title":"Proteasome inhibitor-based primary therapy for antibody-mediated renal allograft rejection","volume":"89","author":"Walsh","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/j.transproceed.2017.05.006_bib11","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1111\/j.1600-6143.2008.02451.x","article-title":"The use of antibody to complement protein C5 for salvage treatment of severe antibody-mediated rejection","volume":"9","author":"Locke","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/j.transproceed.2017.05.006_bib12","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1056\/NEJMoa0706383","article-title":"B-cell depletion with rituximab in relapsing-remitting multiple sclerosis","volume":"358","author":"Hauser","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2017.05.006_bib13","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2002.32418","article-title":"The association between hepatitis C infection and survival after orthotopic liver transplantation","volume":"122","author":"Forman","year":"2002","journal-title":"Gastroenterology"},{"key":"10.1016\/j.transproceed.2017.05.006_bib14","first-page":"Cd006803","article-title":"Antiviral therapy for recurrent liver graft infection with hepatitis C virus","author":"Gurusamy","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.transproceed.2017.05.006_bib15","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1408921","article-title":"An interferon-free antiviral regimen for HCV after liver transplantation","volume":"371","author":"Kwo","year":"2014","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.transproceed.2017.05.006_bib16","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1002\/hep.27113","article-title":"Daclatasvir plus asunaprevir for chronic HCV genotype 1b infection","volume":"59","author":"Kumada","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2017.05.006_bib17","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1002\/hep.27705","article-title":"Randomized trial of interferon- and ribavirin-free ombitasvir\/paritaprevir\/ritonavir in treatment-experienced hepatitis C virus-infected patients","volume":"61","author":"Chayama","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.transproceed.2017.05.006_bib18","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1053\/jlts.2003.50233","article-title":"Hepatitis C virus therapy, hepatocyte drug metabolism, and risk for acute cellular rejection","volume":"9","author":"Kugelmas","year":"2003","journal-title":"Liver Transpl"},{"key":"10.1016\/j.transproceed.2017.05.006_bib19","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.dld.2008.09.015","article-title":"Immune-mediated liver dysfunction after antiviral treatment in liver transplanted patients with hepatitis C: allo or autoimmune de novo hepatitis?","volume":"41","author":"Merli","year":"2009","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.transproceed.2017.05.006_bib20","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/j.1432-2277.2009.01022.x","article-title":"Prevalence of anti-HLA antibodies after liver transplantation","volume":"23","author":"Fontana","year":"2010","journal-title":"Transpl Int"}],"container-title":["Transplantation Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134517304736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0041134517304736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,28]],"date-time":"2018-08-28T09:08:28Z","timestamp":1535447308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0041134517304736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,9]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S0041134517304736"],"URL":"https:\/\/doi.org\/10.1016\/j.transproceed.2017.05.006","relation":{},"ISSN":["0041-1345"],"issn-type":[{"value":"0041-1345","type":"print"}],"subject":[],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acute Graft Rejection and Formation of De Novo Donor-Specific Antibodies Triggered by Low Cyclosporine Levels and Interferon Therapy for Recurrent Hepatitis C Infection After Liver Transplantation: A Case Report","name":"articletitle","label":"Article Title"},{"value":"Transplantation Proceedings","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transproceed.2017.05.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}